Abnormal PRAS40 activation and high levels of phospho-PRAS40 have been indicated as putative biomarkers in melanoma, prostate cancer, and NSCLC [48], but the role of PRAS40 in MPNST or neurofibromatosis has yet to be explored. The gene discussed is AKT1S1; the disease is Familial prostate cancer.